drugset / Trial / NCT01672762

A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients

NCT01672762

Phase 3 Completed 174 enrolled Astellas Pharma Inc
NaSingle-groupOpen-labelTreatment

Summary

This study is to evaluate safety and efficacy of ASP1941 after 24 week administration to diabetic patients.

Timeline

Start
2012-05-25
Primary completion
2013-04-13
Completion
2013-04-13

Drugs

EvaluationDrugModalityDoseRoute
Subject ipragliflozin Small molecule Oral